1997
DOI: 10.1016/s0142-9612(97)00008-2
|View full text |Cite
|
Sign up to set email alerts
|

In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrier

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
60
1
1

Year Published

1998
1998
2009
2009

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 129 publications
(64 citation statements)
references
References 39 publications
2
60
1
1
Order By: Relevance
“…They have been studied for biomedical applications that include tissue, cell and enzyme encapsulation and controlled release of drugs [2,3,[6][7][8][9][10][11][12][13]. Derived from a metal alkoxide precursor, the sol is produced through a hydrolysis and polycondensation reaction [14].…”
Section: Q3mentioning
confidence: 99%
See 2 more Smart Citations
“…They have been studied for biomedical applications that include tissue, cell and enzyme encapsulation and controlled release of drugs [2,3,[6][7][8][9][10][11][12][13]. Derived from a metal alkoxide precursor, the sol is produced through a hydrolysis and polycondensation reaction [14].…”
Section: Q3mentioning
confidence: 99%
“…Due to the mild processing conditions, high concentrations of many types of biologically active agents can be incorporated in the liquid sol. The agents are embedded in the matrix of the gel, which after condensation and drying becomes a porous, glassy solid [2,3,[9][10][11][12][13]. Data show that controlled release of antibiotics, proteins, and growth factors is possible from this porous material [2,[9][10][11][12][13].…”
Section: Q3mentioning
confidence: 99%
See 1 more Smart Citation
“…Ceramics as drug delivery systems were basically in the form of porous materials and using the well-known ceramics mentioned above. As proposed by Ducheyne and co-workers (Nicoll et al, 1997;Santos et al, 1998Santos et al, , 1999, sol-gel technology for the formation of silica-based xerogels, which allows the introduction of functional proteins into glasslike materials, is a very interesting strategy that couples the bioactive behaviour of these systems with drug delivery capability and the additional ability to tailor other properties. Another major advantages relate to room temperature processing without the need for solvents.…”
Section: Incorporation and Releasementioning
confidence: 99%
“…Esta última técnica tem a vantagem de evitar uma possível ligação estável da substância à rede da sílica, o que reduziria a liberação do medicamento. A liberação de uma grande variedade de substâncias, incluindo esteróides 51 , fármacos anti-cancerígenos 52 , antibióticos [53][54][55] , anticoagulantes 56 , fármacos coronarianas 57 , fatores de crescimento 58 e proteínas 59 , tem sido testada. Em geral, a velocidade de liberação das espécies aprisionadas Tabela 1.…”
Section: Emprego Do Método Sol-gel Para Producão De Biocerâmicasunclassified